Max Robotics — Global Service Robot Directory + US Certification

About

Matthew Crockett is a surgeon whose work has been pivotal in maintaining cancer surgery during global health crises. His research focuses on robotic-assisted surgery for colorectal and urological cancers, with a particular emphasis on patient safety and surgical innovation. During the COVID-19 pandemic, Crockett led the establishment of a "COVID protected" robotic surgical centre, a pioneering effort that allowed elective cancer surgeries to continue safely. His most-cited paper (24 citations) details the protocols and outcomes of this unit, demonstrating how to balance urgent surgical needs with infection control. He further refined this model in a subsequent study (13 citations), creating a blueprint for "cold" elective units that has been adopted internationally. Crockett’s work also advances the precision of kidney-sparing surgery; his validation of nephrometry scoring systems (10 citations) provides surgeons with reliable tools to predict outcomes in retroperitoneal robot-assisted partial nephrectomy. By combining technical expertise with crisis-response leadership, Crockett has not only improved surgical safety during pandemics but also set new standards for robotic cancer care, making him a key figure in modern surgical oncology.